Oyster Point Pharma, Inc. OYST

Full chart Compare
Set alert

Price alert · OYST

All alert types
11.17 0.00 (+0.00%)

At closeDec 30, 2022, 4:00 PM EST

11.12 Day range 11.20

52-week range unavailable

Valuation

P/E -4.6×
FY 2017: -25.7×FY 2018: -10.3×FY 2019: -2.5×FY 2020: -6.4×FY 2021: -4.6×
FY 2017 5y median -6.4× FY 2021
P/S 19.4×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 19.4×
FY 2017 5y median 0.0× FY 2021
P/B 4.8×
FY 2017: -7.7×FY 2018: -4.4×FY 2019: 0.8×FY 2020: 2.4×FY 2021: 4.8×
FY 2017 5y median 0.8× FY 2021
P/FCF -5.2×
FY 2017: -36.3×FY 2018: -9.9×FY 2019: -2.7×FY 2020: -7.7×FY 2021: -5.2×
FY 2017 5y median -7.7× FY 2021
EV/EBITDA -3.9×
FY 2017: -24.1×FY 2018: -10.0×FY 2019: 0.6×FY 2020: -3.7×FY 2021: -3.9×
FY 2017 5y median -3.9× FY 2021
EV/Sales 15.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 15.3×
FY 2017 5y median 0.0× FY 2021
FCF Yield -19.1%
FY 2017: -2.8%FY 2018: -10.1%FY 2019: -36.6%FY 2020: -13.0%FY 2021: -19.1%
FY 2017 5y median -13.0% FY 2021

Profitability

Gross Margin 93.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 93.8%
FY 2017 5y median 0.0% FY 2021
Operating Margin -395.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -395.0%
FY 2017 5y median 0.0% FY 2021
Net Margin -425.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -425.4%
FY 2017 5y median 0.0% FY 2021
ROE -104.9%
FY 2017: 30.1%FY 2018: 43.2%FY 2019: -33.3%FY 2020: -37.8%FY 2021: -104.9%
FY 2017 5y median -33.3% FY 2021
ROIC -49.8%
FY 2017: -26.9%FY 2018: -351.3%FY 2019: -34.2%FY 2020: -37.9%FY 2021: -49.8%
FY 2017 5y median -37.9% FY 2021
ROA -46.9%
FY 2017: -28.5%FY 2018: -289.3%FY 2019: -31.9%FY 2020: -35.6%FY 2021: -46.9%
FY 2017 5y median -35.6% FY 2021

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2017 FY 2021
Operating Income -36.5%
FY 2017: 0.0%FY 2018: -194.5%FY 2019: -182.6%FY 2020: -50.1%FY 2021: -36.5%
FY 2017 FY 2021
EPS (diluted) -37.3%
FY 2017: 0.0%FY 2018: -150.7%FY 2019: -444.8%FY 2020: 70.7%FY 2021: -37.3%
FY 2017 FY 2021
Free Cash Flow -53.7%
FY 2017: 0.0%FY 2018: -265.5%FY 2019: -140.1%FY 2020: -44.1%FY 2021: -53.7%
FY 2017 FY 2021

Financial Health

Current Ratio 7.5×
FY 2017: 11.2×FY 2018: 6.0×FY 2019: 26.3×FY 2020: 17.9×FY 2021: 7.5×
FY 2017 5y median 11.2× FY 2021
Quick Ratio 7.3×
FY 2017: 11.2×FY 2018: 6.0×FY 2019: 26.3×FY 2020: 17.9×FY 2021: 7.3×
FY 2017 5y median 11.2× FY 2021
Debt / Equity 0.9×
FY 2017: 0.0×FY 2018: -0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.9×
FY 2017 5y median 0.0× FY 2021
Net Debt / EBITDA 1.0×
FY 2017: 3.6×FY 2018: 0.3×FY 2019: 3.0×FY 2020: 2.7×FY 2021: 1.0×
FY 2017 5y median 2.7× FY 2021
Interest Coverage -26.0×
FY 2017: -11.6×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -26.0×
FY 2017 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2017 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2017 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31